Drug Shortage Report for PMS-LOSARTAN-HCTZ

Last updated on 2019-06-29 History
Report ID 49747
Drug Identification Number 02392232
Brand name PMS-LOSARTAN-HCTZ
Common or Proper name LOSARTAN
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-30
Actual start date 2018-06-04
Estimated end date 2019-06-04
Actual end date 2019-06-28
Shortage status Resolved
Updated date 2019-06-29
Company comments RESOLVED
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2019-06-29 English Compare
v23 2019-06-28 French Compare
v22 2019-06-28 French Compare
v21 2019-06-28 English Compare
v20 2019-06-28 English Compare
v19 2019-06-11 French Compare
v18 2019-06-11 English Compare
v17 2019-05-09 French Compare
v16 2019-05-09 English Compare
v15 2019-03-29 French Compare
v14 2019-03-29 English Compare
v13 2019-01-16 French Compare
v12 2019-01-16 English Compare
v11 2018-11-29 French Compare
v10 2018-11-29 English Compare
v9 2018-08-24 French Compare
v8 2018-08-24 English Compare
v7 2018-07-13 French Compare
v6 2018-07-13 English Compare
v5 2018-06-06 French Compare

Showing 1 to 20 of 24